Q2 marked our strongest quarter of investment performance since launching the fund nearly 3.5 years ago. Read more here.

Besides Wall Street's top-and-bottom-line estimates for Edwards Lifesciences (EW), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared ...